newsfilter
← Latest News
PR Newswire·

BAX SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Baxter International

  • Faruqi & Faruqi, LLP is investigating potential securities claims against Baxter International Inc. (NYSE: BAX) regarding its Novum LVP infusion pumps.
  • The lawsuit alleges Baxter violated federal securities laws by failing to disclose systemic defects in the Novum LVP that caused malfunctions, patient injuries, & deaths.
  • The firm claims Baxter was aware of device failures yet provided inadequate remedial measures while making materially false statements about product safety & sales prospects.
  • The fraud was revealed on July 31, 2025, when Baxter paused shipments & installations of the Novum LVP, causing stock to drop 22.4% to close at $21.76.
  • Investors who suffered losses between February 23, 2022, and July 30, 2025, are encouraged to contact partner James (Josh) Wilson to discuss legal options.
  • The deadline to seek the role of lead plaintiff in the federal securities class action is December 15, 2025.
  • The firm is also seeking information from whistleblowers, former employees, & shareholders regarding Baxter's conduct.
  • Contact details for the firm include phone numbers 877-247-4292 or 212-983-9330 (Ext. 1310) & website www.faruqilaw.com/BAX.